The world-renowned experts at the OSUCCC – James are transforming the way cancers are prevented, detected, treated and, yes, cured.

Today, cancer is no longer solely defined by location or even by stage. We know there is no routine cancer.

Cancer is a complex disease. Each patient’s cancer is different, behaving differently in the body and calling for a tailored, individualized treatment plan for each patient.

To deliver the most effective cancer treatment, our experts identify and understand cancer at the biologic and genetic levels, unlocking the molecular code of a patient’s disease and pinpointing what makes each cancer grow—then discovering what stops it.

Our team of sub-specialists spans a broad range of disciplines: from medical, surgical and radiation oncologists to molecular and biological pathologists, genetic scientists and more—all specializing in cancer research, prevention, detection, treatment and cure.  

It’s that sub-specialization and singular focus that enables us to discover, develop and deliver targeted therapies for each individual patient.  

And that means our collective expertise leads to improved outcomes, faster responses, fewer side effects and more hope for cancer patients everywhere.

Make an Appointment

If you’ve been diagnosed with cancer, would like a second opinion or would like to speak to a cancer specialist, please call the James Line at 800-293-5066 or 614-293-5066 to make an appointment.

An oncology nurse will discuss your needs, schedule an appointment and review the items you will need to bring with you to your first appointment.

In addition, you will be sent an information packet with more details about planning for your first visit.

Make an Appointment

800-293-5066

Contact The James

General Inquiries


800-293-5066


Email



Address


460 W. 10th Avenue
Columbus, OH 43210


Get Your Medical Records


614-293-8657


Get Your Medical Bills


614-293-2100


Online Bill Pay



Contact Us

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More